Mannatech
This article was originally published in The Tan Sheet
Executive Summary
September launch of Ambrotose A.O. antioxidant supplement helps boost revenues 44.1% to $49.7 mil. for the third quarter ended Sept. 30 versus the prior-year period, Coppell, Texas-based direct marketer reports Nov. 7. CEO Sam Caster believes the product could total 25% of Mannatech's gross sales by 2005 (1"The Tan Sheet" Aug. 25, 2003, p. 15). Mannatech's net income rose to $2.9 mil. compared with $200,000 in the year-ago period...
You may also be interested in...
Mannatech results
Dietary supplement direct seller reports consolidated net sales increase of 35.6% to $191 mil. in 2003, as income more than tripled over the prior year to $8.8 mil. Coppell, Texas-based company recorded sales of $54.3 mil. in the fourth quarter, up 9.2% over same period in 2002. Mannatech attributes improved annual performance in part to antioxidant product Ambrotose AO, launched last September (1"The Tan Sheet" Nov. 17, 2003, In Brief). Firm plans launches in South Korea in second half of 2004 and Taiwan in first quarter 2005...
Mannatech Posts Solid Q2; Launching Antioxidant, Intestinal Products
Mannatech's new antioxidant supplement, Ambrotose A.O., could represent 25% of the company's gross sales worldwide by 2005, according to company CEO Sam Caster
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.